![Sina Bavari](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sina Bavari
Corporate Officer/Principal presso TONIX PHARMACEUTICALS HOLDING CORP.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Seth Lederman | M | 66 | 17 anni | |
Jessica Morris | F | 46 | 11 anni | |
Bruce Daugherty | M | 66 | 12 anni | |
Bradley Saenger | M | 50 | 10 anni | |
David Grange | M | 76 | 6 anni | |
Richard Bagger | M | 63 | 4 anni | |
Adeoye Olukotun | M | 79 | 6 anni | |
R. Stillwell | M | 67 | 1 anni | |
Jamie Treco | M | 69 | 5 anni | |
Simon Newman | M | - |
Healion Bio, Inc.
![]() Healion Bio, Inc. BiotechnologyHealth Technology Part of Tonix Pharmaceuticals Holding Corp., Healion Bio, Inc. is a biotechnology development company based in Frederick, MD. The company is focused on developing the next generation of antiviral compounds, with two antiviral platforms: the HB-100 series of protease inhibitors and the HB-200/300 series of next-generation antiviral biologics. The HB-100 series is a first-in-class antiviral with an orthogonal mechanism of action to existing drugs. The company was founded by Sina Bavari and Simon Newman, with Simon Newman serving as CEO since incorporation. Healion Bio was acquired by Tonix Pharmaceuticals Holding Corp. on February 01, 2023 for $1.20 million. | - |
Gregory Sullivan | M | 58 | 14 anni | |
Margaret Bell | F | 64 | 7 anni | |
Carolyn Taylor | F | 64 | 3 anni | |
Zeil Rosenberg | M | - | 1 anni | |
Anthony Macaluso | M | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Jeffrey Rosenfeld | M | - | 2 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Stati Uniti | 16 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Sina Bavari
- Contatti personali